Curex vs ShedRx
Two GLP-1 desks, one scoreboard. We put Curex and ShedRx head-to-head on the published Brief Score — the same six factors, scored the same way.
Curex
FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.
ShedRx
The verdict
ShedRx takes this head-to-head.
ShedRx scores 87 to 86 on our six-factor Brief Score — A weight-focused program with a low tracked tirzepatide rate and an oral/sublingual route for the needle-averse.
That doesn't make Curex a bad call — it's best for readers who want one predictable price across sema and tirz from an accredited, nationwide desk. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Curex | ShedRx | |
|---|---|---|
| Brief Score | 86/100 (B) | 87/100 (B+) |
| Semaglutide | $199/mo | $199/mo |
| Tirzepatide | $199/mo | $299/mo |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
| On the tracker | Stableprice stable | Fallingprice falling |
Curex: Flat $199 on both molecules; LegitScript-certified and nationwide.
ShedRx: Competitive tirzepatide rate trimmed further this cycle — cheapest tirz among our partner desks.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.